Affinity apheresis for treatment of bacteremia caused by Staphylococcus Faureus and/or methicillin-resistant S. aureus (MRSA)

Journal of Microbiology and Biotechnology

Volumn 21, Issue 6, 2011, Pages 659-664

  Mattsby Baltzer, Inger ^a   Bergström, Tomas ^a   McCrea, Keith ^b   Ward, Robert ^b   Adolfsson, Lars ^c   Larm, Olle ^c  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b Emergence LLC   (United States)

^c ExThera AB   (Sweden)

Author keywords

Apheresis; Bacteria; Immobilized heparin; MRSA; Staphylococcus aureus

Indexed keywords

HEPARIN;

APHERESIS; ARTICLE; BACTEREMIA; BACTERIAL STRAIN; BACTERIUM CULTURE; BINDING AFFINITY; COLONY FORMING UNIT; CONTROLLED STUDY; GENE SEQUENCE; IONIC STRENGTH; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORTALITY; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; STAPHYLOCOCCUS AUREUS;

BACTEREMIA; BACTERIAL ADHESION; BIOTECHNOLOGY; BLOOD COMPONENT REMOVAL; COLONY COUNT, MICROBIAL; CROSS INFECTION; HEPARIN; HUMANS; IMMOBILIZATION; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROSPHERES; POLYETHYLENE; POLYMERASE CHAIN REACTION; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

BACTERIA (MICROORGANISMS); METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS;

EID: 79959935289     PISSN: 10177825     EISSN: 17388872     Source Type: Journal    
DOI: 10.4014/jmb.1102.02016     Document Type: Article

References (37)

1. Axelsson, J., M. Ferreira, L. Adolfsson, K. McCrea, R. Ward, and O. Larm. 2010. Cytokines in blood from septic patients interact with surface-immobilized heparin. ASAIO J. 56: 48-51.
2. Brakstad, O. G., K. Aasbakk, and J. A. Maeland. 1992. Detection of Staphylococcus aureus by polymerase chain reaction amplification of the nuc gene. J. Clin. Microbiol. 30: 1654-1660.
3. Brandtzaeg, P., A. Bjerre, R. Ovstebo, B. Brusletto, G. B. Joo, and P. Kierulf. 2001. Neisseria meningitidis lipopolysaccharides in human pathology. J. Endotoxin Res. 7: 401-420.
4. Cai, B., E. A. Deitch, and L. Ulloa. 2010. Novel insights for systemic inflammation in sepsis and hemorrhage. Mediators Inflamm. 2010: 642462.
5. Carleton, H. A., B. A. Diep, E. D. Charlebois, G. F. Sensabaugh, and F. Perdreau-Remington. 2004. Community-adapted methicillinresistant Staphylococcus aureus (MRSA): Population dynamics of an expanding community reservoir of MRSA. J. Infect. Dis. 190: 1730-1738.
6. Cosgrove, S. E., G. Sakoulas, E. N. Perencevich, M. J. Schwaber, A. W. Karchmer, and Y. Carmeli. 2003. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: A meta-analysis. Clin. Infect. Dis. 36: 53-59.
7. David, M. Z. and R. S. Daum. 2010. Community-associated methicillin-resistant Staphylococcus aureus: Epidemiology and clinical consequences of an emerging epidemic. Clin. Microbiol. Rev. 23: 616-687.
8. Hackett, S. J., M. Guiver, J. Marsh, J. A. Sills, A. P. Thomson, E. B. Kaczmarski, and C. A. Hart. 2002. Meningococcal bacterial DNA load at presentation correlates with disease severity. Arch. Dis. Child. 86: 44-46.
9. Hess, D. J., M. J. Henry-Stanley, S. L. Erlandsen, and C. L. Wells. 2006. Heparan sulfate proteoglycans mediate Staphylococcus aureus interactions with intestinal epithelium. Med. Microbiol. Immunol. 195: 133-141.
10. Hsu, R. B. 2005. Risk factors for nosocomial infective endocarditis in patients with methicillin-resistant Staphylococcus aureus bacteremia. Infect. Control Hosp. Epidemiol. 26: 654-657.
11. Jessen, M. E. 2006. Pro: Heparin-coated circuits should be used for cardiopulmonary bypass. Anesth. Analg. 103: 1365-1369.
12. Kollef, M. H. 2000. Inadequate antimicrobial treatment: An important determinant of outcome for hospitalized patients. Clin. Infect. Dis. 31 (Suppl 4): S131-S138.
13. Lala, H. M., G. D. Mills, K. Barratt, J. Bonning, N. E. Manikkam, and D. Martin. 2007. Meningococcal disease deaths and the frequency of antibiotic administration delays. J. Infect. 54: 551-557.
14. Larm, O., R. Larsson, and P. Olsson. 1983. A new non-thrombogenic surface prepared by selective covalent binding of heparin via a modified reducing terminal residue. Biomater. Med. Devices Artif. Organs 11: 161-173.
15. Liang, O. D., F. Ascencio, L. A. Fransson, and T. Wadstrom. 1992. Binding of heparan sulfate to Staphylococcus aureus. Infect. Immun. 60: 899-906.
16. Liang, O. D., F. Ascencio, R. Vazquezjuarez, and T. Wadstrom. 1993. Binding of collagen, fibronectin, lactoferrin, laminin, vitronectin and heparan-sulfate to Staphylococcus aureus strain-V8 at various growth phases and under nutrient stress conditions. Zentralbl. Bakteriol. Microbiol. Hyg. A 279: 180-190.
17. Lisboa, T., G. Waterer, and J. Rello. 2010. We should be measuring genomic bacterial load and virulence factors. Crit. Care Med. 38: S656-S662.
18. Ljungh, A. and T. Wadstrom. 1995. Growth-conditions influence expression of cell-surface hydrophobicity of staphylococci and other wound-infection pathogens. Microbiol. Immunol. 39: 753-757.
19. Lowy, F. D. 1998. Staphylococcus aureus infections. N Engl. J. Med. 339: 520-532.
20. Olofsson, S. and T. Bergstrom. 2005. Glycoconjugate glycans as viral receptors. Ann. Med. 37: 154-172.
21. Ovstebo, R., P. Brandtzaeg, B. Brusletto, K. B. Haug, K. Lande, E. A. Hoiby, and P. Kierulf. 2004. Use of robotized DNA isolation and real-time PCR to quantify and identify close correlation between levels of Neisseria meningitidis DNA and lipopolysaccharides in plasma and cerebrospinal fluid from patients with systemic meningococcal disease. J. Clin. Microbiol. 42: 2980-2987.
22. Payen, D., J. Mateo, J. M. Cavaillon, F. Fraisse, C. Floriot, and E. Vicaut. 2009. Impact of continuous venovenous hemofiltration on organ failure during the early phase of severe sepsis: A randomized controlled trial. Crit. Care Med. 37: 803-810.
23. Pertosa, G., G. Grandaliano, L. Gesualdo, and F. P. Schena. 2000. Clinical relevance of cytokine production in hemodialysis. Kidney Int. 76: S104-S111.
24. Peters, R. P., M. A. van Agtmael, S. Gierveld, S. A. Danner, A. B. Groeneveld, C. M. Vandenbroucke-Grauls, and P. H. Savelkoul. 2007. Quantitative detection of Staphylococcus aureus and Enterococcus faecalis DNA in blood to diagnose bacteremia in patients in the intensive care unit. J. Clin. Microbiol. 45: 3641-3646.
25. Rello, J., T. Lisboa, M. Lujan, M. Gallego, C. Kee, I. Kay, D. Lopez, and G. W. Waterer. 2009. Severity of pneumococcal pneumonia associated with genomic bacterial load. Chest 136: 832-840.
26. Riesenfeld, J. and L. Roden. 1990. Quantitative analysis of Nsulfated, N-acetylated, and unsubstituted glucosamine amino groups in heparin and related polysaccharides. Anal. Biochem. 188: 383-389.
27. Ronco, C., R. Bellomo, P. Homel, A. Brendolan, M. Dan, P. Piccinni, and G. La Greca. 2000. Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: A prospective randomised trial. Lancet 356: 26-30.
28. Schefold, J. C., S. von Haehling, M. Corsepius, C. Pohle, P. Kruschke, H. Zuckermann, H. D. Volk, and P. Reinke. 2007. A novel selective extracorporeal intervention in sepsis: Immunoadsorption of endotoxin, interleukin 6, and complementactivating product 5a. Shock 28: 418-425.
29. Segreti, J. 2005. Efficacy of current agents used in the treatment of Gram-positive infections and the consequences of resistance. Clin. Microbiol. Infect. 11 (Suppl 3): 29-35.
30. Tang, L. and J. W. Eaton. 1995. Inflammatory responses to biomaterials. Am. J. Clin. Pathol. 103: 466-471.
31. Tetta, C., V. D'Intini, R. Bellomo, M. Bonello, V. Bordoni, Z. Ricci, and C. Ronco. 2003. Extracorporeal treatments in sepsis: Are there new perspectives? Clin. Nephrol. 60: 299-304.
32. Wadstrom, T. and A. Ljungh. 1999. Glycosaminoglycan-binding microbial proteins in tissue adhesion and invasion: Key events in microbial pathogenicity. J. Med. Microbiol. 48: 223-233.
33. Valente, A. M., R. Jain, M. Scheurer, V. G. Fowler Jr., G. R. Corey, A. R. Bengur, S. Sanders, and J. S. Li. 2005. Frequency of infective endocarditis among infants and children with Staphylococcus aureus bacteremia. Pediatrics 115: e15-e19.
34. van der Poll, T. and S. M. Opal. 2008. Host-pathogen interactions in sepsis. Lancet Infect. Dis. 8: 32-43.
35. van Haeften, R., S. Palladino, I. Kay, T. Keil, C. Heath, and G. W. Waterer. 2003. A quantitative LightCycler PCR to detect Streptococcus pneumoniae in blood and CSF. Diagn. Microbiol. Infect. Dis. 47: 407-414.
36. Venkataraman, R., S. Subramanian, and J. A. Kellum. 2003. Clinical review: Extracorporeal blood purification in severe sepsis. Crit. Care 7: 139-145.
37. Wisplinghoff, H., T. Bischoff, S. M. Tallent, H. Seifert, R. P. Wenzel, and M. B. Edmond. 2004. Nosocomial bloodstream infections in US hospitals: Analysis of 24,179 cases from a prospective nationwide surveillance study. Clin. Infect. Dis. 39: 309-317.